Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas

Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1054-61. doi: 10.1097/00042737-199611000-00005.

Abstract

Most cases of antibiotic-associated diarrhoea are due to Clostridium difficile or are enigmatic. Patients with C. difficile-associated disease are more likely to have colitis, severe disease and nosocomial acquisition. The preferred diagnostic test is a C. difficile toxin assay using a tissue culture assay or enzyme immunoassay. The usual treatment is withdrawal of the inducing agent, sometimes supplemented with oral vancomycin or metronidazole. Response rates approach 100%; the major complication is relapse. Major complications include toxic megacolon, devastating diarrhoea, pseudomembranous colitis and hypoalbuminemia. Antibiotic-associated diarrhoea with negative tests for C. difficile toxin is usually dose-related and responds to antibiotic withdrawal.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile / isolation & purification*
  • Diarrhea* / chemically induced
  • Diarrhea* / physiopathology
  • Diarrhea* / therapy
  • Enterocolitis, Pseudomembranous* / diagnosis
  • Enterocolitis, Pseudomembranous* / physiopathology
  • Enterocolitis, Pseudomembranous* / therapy
  • Humans
  • Prognosis

Substances

  • Anti-Bacterial Agents